The Latin American soft tissue repair market is anticipated to grow at a 7.84% CAGR from 2022 to 2027. The size of the Latin American market was valued at USD 1.77 billion in 2022 and is predicted to be worth USD 2.58 billion by 2027.
Soft tissue repair is a technique for restoring the functions of damaged or injured tissues such as ligaments, muscles, and other tissues. Soft tissue repair can be accomplished through surgical meshes such as allografts, xenografts, alloplastic, and synthetic.
The major factors driving the Latin American soft tissue repair market are the rise in the count of geriatric population, obesity, and growing awareness of tissue injuries. Moreover, the rising sports-related injuries and increasing healthcare expenditure are other factors likely to fuel market growth. However, the high cost of treatment, lack of expertise, and an ambiguous reimbursement scenario are reasonable to curtail market growth. Primary factors driving the growth of the global soft tissue repair market are increasing disposable income and changing lifestyles among populations in developing economies. Moreover, a rise in the geriatric population, increasing hernia repairs, and the growing incidence of breast cancer drive global demand for wound care and soft tissue repair products.
However, ethical concerns arising from a cultural aversion towards using tissue from human cadavers and stringent regulations for biological meshes are expected to hamper the growth of Latin America's soft tissue repair market.
This research report on the Latin America soft tissue repair market has been segmented and sub-segmented into the following categories:
Regionally, the Latin American region is predicted to have steady growth during the forecast period. Factors such as the growing older people population, obesity rates, and having sound knowledge of tissue injuries are propelling the market growth in this region. In addition, increasing the amount spent on healthcare is another factor boosting this region's soft tissue repair market growth.
The Brazilian soft tissue repair market led the Latin American market in 2019 and is estimated to grow at the highest CAGR during the forecast period. The increasing stipulation of soft tissue repair devices and the increasing economy is surging the market's growth rate. In addition, the increasing geriatric population and growing occurrences of breast cancer and breast cancer for soft tissue repair products further support the market.
KEY MARKET PLAYERS:
Companies profiled in the report that are playing a prominent role in the Latin America soft tissue repair market are LifeCell Corporation, Organogenesis, C.R. Bard Inc., Johnson & Johnson, Covidien plc, Arthrex Inc., Smith & Nephew plc, Integra Lifesciences Corporation, Wright Medical Technology, and Stryker Corporation.
The Latin American soft tissue repair market is estimated to grow at a CAGR of 7.84% from 2022 to 2027.
Brazil, Mexico, Argentina, and Chile are covered in this report.
Johnson & Johnson, Medtronic, Smith & Nephew, Stryker, Tissue Regenix Group, Neosurgery, and Bioregen are some of the noteworthy companies in the Latin American soft tissue repair market.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]